Medical Disclaimer: Compounded GLP-1 medications (semaglutide, tirzepatide) are not FDA-approved; they are produced by state-licensed 503A or 503B compounding pharmacies under patient-specific prescriptions. Branded products (Wegovy, Zepbound, Mounjaro, Ozempic) are FDA-approved for specific indications. Content on GLP1CompareHub is educational and is not medical advice — consult a licensed prescriber before starting, stopping, or modifying any GLP-1 medication. Full medical disclaimer.
TMates vs Eden Health 2026: Which Compounded GLP-1 Provider Wins?
Updated May 2026 · Pricing verified directly from provider sites and Trustpilot/BBB filings
Pick TMates if:
You are budget-conscious, willing to commit to a 12-month plan ($158/mo flat for semaglutide, $167/mo for tirzepatide), and you want predictable pricing that does not increase as you titrate up to higher doses. Best for users who already know they want compounded GLP-1.
See TMates PricingPick Eden Health if:
You are a first-time GLP-1 user who values pharmacy accreditation transparency, you want the option to step up to branded Wegovy or Zepbound later, you place weight on consumer trust signals (Trustpilot 4.4+/5), or you want money-back guarantees. Eden Health is the lower-risk choice for newcomers.
See Eden Health PricingSide-by-Side Comparison
| Factor | TMates | Eden Health |
|---|---|---|
| Compounded Semaglutide | $158–$249/mo (flat across doses) | $129–$149 intro / $209–$229 ongoing |
| Compounded Tirzepatide | $167–$297/mo (flat across doses) | $249 first / $329/mo ongoing |
| 503A Pharmacy | U.S. 503A (specific partner not publicly disclosed) | NABP/PCAB/ACHC-accredited 503A + 3rd-party batch testing |
| Trustpilot | 3.2/5 (low review volume) | 4.4+/5 (high volume, positive) |
| Cancel Policy | Cancel anytime, no contract | Cancel anytime, money-back elements |
| Pricing Model | Same flat price across all doses (rare in industry) | Tiered pricing + branded GLP-1 access + accredited pharmacy partners |
Where Eden Health Beats TMates
- Discloses NABP, PCAB, and ACHC accreditations for its 503A pharmacy partners — transparent third-party batch testing.
- Offers branded Wegovy, Zepbound, Ozempic, and Mounjaro via insurance concierge or ~$1,399 cash-pay.
- Stronger Trustpilot reputation (4.4+/5 across thousands of reviews) vs TMates 3.2/5 on lower volume.
- Same-day or synchronous video consultations available, not just async intake.
- Money-back guarantee elements present in some plans (verify on signup).
Where TMates Beats Eden Health
- TMates has flat pricing across all doses — Eden Health charges more as you titrate up to higher tiers.
- On a 12-month TMates plan ($158/mo semaglutide), TMates is dramatically cheaper than Eden Health ongoing.
- TMates has avoided the FDA marketing-warning wave of Feb-Mar 2026 that hit several major telehealth providers.
- TMates 12-month commitment beats Eden Health ongoing pricing for users who plan to titrate to higher doses.
Honest Take: Where TMates Falls Short
TMates does not publicly disclose its 503A pharmacy partners or accreditation (no NABP/PCAB/ACHC publicly listed), has a lower Trustpilot score (3.2/5) on a smaller review volume, and has 9 BBB complaints about service and sales. For consumers who weight pharmacy transparency and consumer trust signals heavily, this is a real concern. The flat-dose pricing model is genuinely innovative but does not erase those gaps.
Red Flag to Know About Eden Health
Eden Health pricing increases with dose tier — a user titrated to 15 mg tirzepatide will pay materially more than at 2.5 mg. Confirm exact pricing for your target dose at signup, not just intro-month pricing.
Related Guides
Continue your research with these related independent reviews.